MedTrace Logo

Use of Dexamethasone Via Two Different Methods in PENG Block

NCT06242028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2025-02-24

No results posted yet for this study

Summary

Hip fractures are morbid conditions, especially in elderly patients, and their treatment is usually surgical. Pericapsular nerve group block targets the hip capsule. The aim of this study is to investigate and compare the perioperative analgesic efficacy of PENG blocks applied investigation of the effect of perinuerally and systemic dexamethasone on pain scores in the first 24 hours of PENG block in patients undergoing hip fracture surgery under spinal anesthesia.

Conditions

  • Pain, Acute
  • Postoperative Pain
  • Hip Fractures

Interventions

DRUG

Group P

In this group, US guided PENG block will be performed with 20 cc 0.25% bupivacaine and 4 mg dexamethasone.

DRUG

Group S

In this group, US guided PENG block will be performed with 20 cc 0.25% bupivacaine. In addition, 4 mg dexamethasone will be administered intravenously.

Sponsors & Collaborators

  • Ondokuz Mayıs University

    lead OTHER

Principal Investigators

  • Ebru Kelsaka, Prof.Dr · Ondokuz Mayıs University

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-30
Primary Completion
2023-10-30
Completion
2024-02-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06242028 on ClinicalTrials.gov